The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-23-060 |
| Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-23-059 |
| NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) |
93.173 |
PAR-24-051 |
| Down Syndrome Cohort Research Sites (DS-CRS) for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U01 Clinical Trial Not Allowed) |
93.172, 93.233, 93.837, 93.838, 93.839, 93.840, 93.846, 93.865, 93.866 |
RFA-OD-24-003 |
| NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) |
93.173 |
PAR-24-050 |
| Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed) |
93.172, 93.847, 93.865, 93.866 |
RFA-OD-24-004 |
| Down Syndrome Clinical Cohort Coordinating Center (DS-4C) for the INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) (U54 Clinical Trial Not Allowed) |
93.172, 93.233, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.865, 93.866 |
RFA-OD-24-005 |
| HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed) |
93.213, 93.865 |
RFA-HD-24-014 |
| Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
93.173, 93.350, 93.865 |
PAR-24-046 |
| HEAL Initiative: Limited Competition: Data Coordinating Center for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (U24 Clinical Trial Not Allowed) |
93.213, 93.865 |
RFA-HD-24-015 |
| Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required) |
93.853, 93.866 |
RFA-NS-24-013 |
| Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) |
93.242, 93.307, 93.313, 93.361, 93.846, 93.865 |
PAR-24-059 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) |
93.847 |
RFA-DK-25-003 |
| Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-24-040 |
| Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-25-013 |
| F24AS00074 FY24 Candidate Species Conservation |
15.660 |
F24AS00074 |
| F24AS00431 FY24 Recovery Implementation |
15.657 |
F24AS00431 |
| Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional) |
93.307 |
RFA-MD-24-001 |
| Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional) |
93.273 |
RFA-AA-23-004 |
| Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-25-012 |
| Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) |
93.242, 93.310, 93.350, 93.865 |
PAR-24-045 |
| Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-24-030 |
| ROSS (Resident Opportunity and Self-Sufficiency) Service Coordinator Program - FY2023 - NOFO |
14.870 |
FR-6700-N-05 |
| Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional) |
93.393, 93.395, 93.399 |
RFA-CA-24-006 |
| Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) |
93.307, 93.313, 93.361, 93.393, 93.866 |
PAR-23-303 |
| Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) |
93.307, 93.313, 93.361 |
PAR-23-304 |
| FY24 Bureau of Land Management Wild Horse and Burro Resource Management - Off Range |
15.229 |
L24AS00087 |
| Head Start/Early Head Start Recipient -- Communities in Puerto Rico |
93.600 |
HHS-2024-ACF-OHS-CH-R2-0090 |
| Head Start/Early Head Start Recipient -- Communities in the state of Connecticut |
93.600 |
HHS-2024-ACF-OHS-CH-R1-0099 |
| Head Start/Early Head Start Recipient -- Communities in the state of Kansas |
93.600 |
HHS-2024-ACF-OHS-CH-R7-0092 |
| Section 811 Supportive Housing for Persons with Disabilities (Capital Advance) |
14.181 |
FR-6700-N-49 |
| Section 811 Project Rental Assistance for Persons with Disabilities |
14.326 |
FR-6700-N-53 |
| Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) |
93.351, 93.859 |
PAR-24-028 |
| Head Start/Early Head Start Recipient -- Communities in the state of Alaska |
93.600 |
HHS-2024-ACF-OHS-CH-R10-0113 |
| Head Start/Early Head Start Recipient -- Communities in the state of Maine |
93.600 |
HHS-2024-ACF-OHS-CH-R1-0101 |
| Head Start/Early Head Start Recipient -- Communities in the state of Massachusetts |
93.600 |
HHS-2024-ACF-OHS-CH-R1-0100 |
| Head Start/Early Head Start Recipient -- Communities in the state of Colorado |
93.600 |
HHS-2024-ACF-OHS-CH-R8-0112 |
| F24AS00062 National Fish Passage Program Bipartisan Infrastructure Law: Restoring River, Floodplain, and Coastal Connectivity and Resiliency |
15.685 |
F24AS00062 |
| Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed) |
93.847, 93.855 |
RFA-DK-23-004 |
| FY24 IIJA/IRA Bureau of Land Management Oregon/Washington (ORWA) Rangeland Resource Management |
15.237 |
L24AS00048 |
Search Results 561-600 of 17615
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 [Next] |
